Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01301014 · ClinicalTrials.gov registry record
Reliability and Diagnostic Accuracy of an Alternate Lachman's Test Performed in a Prone Position
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 57
- Enrollment target
NCT01301014: Completed study, sponsored by University of Texas Southwestern Medical Center.
NCT01301014 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 57 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01301014 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 57 participants
- Enrollment target
Study Summary
This study is investigating the reliability and diagnostic accuracy of a Lachman's test conducted in a prone position to detect the presence of a torn anterior cruciate ligament.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2010-09 |
| Est. Completion | 2010-12 |
What the finished NCT01301014 record still lists
NCT01301014 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 57 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01301014 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01301014 about?
NCT01301014 is a clinical study titled "Reliability and Diagnostic Accuracy of an Alternate Lachman's Test Performed in a Prone Position". This study is investigating the reliability and diagnostic accuracy of a Lachman's test conducted in a prone position to detect the presence of a torn anterior cruciate ligament.
What is the current status of trial NCT01301014?
This trial is currently completed. The enrollment target is 57 participants. The study started on 2010-09. Estimated completion is 2010-12.
Who is sponsoring clinical trial NCT01301014?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia